| Cancer pain education: a call for role models |
| DE Weissman |
|
JCO Dec 1 1988: 1793–1794.
[PDF]
|
 |
| Evaluating quality and quantity of life in breast cancer adjuvant trials |
| JH Fetting |
|
JCO Dec 1 1988: 1795–1797.
[PDF]
|
 |
|
Quality of life in stage II breast cancer: an instrument for clinical trials |
| |
MN Levine, GH Guyatt, M Gent, S De Pauw, MD Goodyear, WM Hryniuk, A Arnold, B Findlay, JR Skillings, and VH Bramwell |
| |
JCO Dec 1 1988: 1798–1810.
[Abstract]
[PDF]
|
 |
|
Cisplatin as first-line therapy for metastatic breast cancer |
| |
GW Sledge, Jr, Sr Loehrer PJ, BJ Roth, and LH Einhorn |
| |
JCO Dec 1 1988: 1811–1814.
[Abstract]
[PDF]
|
 |
|
A new biomarker in monitoring breast cancer: CA 549 |
| |
RA Beveridge, DW Chan, D Bruzek, D Damron, KR Bray, PK Gaur, DS Ettinger, RC Rock, MS Shurbaji, and FP Kuhajda |
| |
JCO Dec 1 1988: 1815–1821.
[Abstract]
[PDF]
|
 |
|
Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease |
| |
SJ Horning, RT Hoppe, SL Hancock, and SA Rosenberg |
| |
JCO Dec 1 1988: 1822–1831.
[Abstract]
[PDF]
|
 |
|
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management |
| |
A Surbone, DL Longo, VT DeVita, Jr, DC Ihde, PL Duffey, ES Jaffe, D Solomon, SM Hubbard, and RC Young |
| |
JCO Dec 1 1988: 1832–1837.
[Abstract]
[PDF]
|
 |
|
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma |
| |
JM Vose, JO Armitage, DD Weisenburger, PJ Bierman, S Sorensen, M Hutchins, DF Moravec, D Howe, MD Dowling, and J Mailliard |
| |
JCO Dec 1 1988: 1838–1844.
[Abstract]
[PDF]
|
 |
|
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease |
| |
H Ekert, KD Waters, PJ Smith, I Toogood, and D Mauger |
| |
JCO Dec 1 1988: 1845–1850.
[Abstract]
[PDF]
|
 |
|
Partially matched bone marrow transplantation in patients with myelodysplastic syndromes |
| |
NJ Bunin, JT Casper, C Chitambar, J Hunter, R Truitt, J Menitove, BM Camitta, and R Ash |
| |
JCO Dec 1 1988: 1851–1855.
[Abstract]
[PDF]
|
 |
|
Radiotherapy for stage 2 testicular seminoma: the prognostic influence of tumor bulk |
| |
BR Mason and JH Kearsley |
| |
JCO Dec 1 1988: 1856–1862.
[Abstract]
[PDF]
|
 |
|
Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma |
| |
S Pilotti, F Rilke, C Bartoli, and A Grisotti |
| |
JCO Dec 1 1988: 1863–1873.
[Abstract]
[PDF]
|
 |
|
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma |
| |
GM Brodeur, RC Seeger, A Barrett, F Berthold, RP Castleberry, G D'Angio, B De Bernardi, AE Evans, M Favrot, and AI Freeman |
| |
JCO Dec 1 1988: 1874–1881.
[Abstract]
[PDF]
|
 |
|
Pharmacokinetics of subcutaneous methotrexate |
| |
FM Balis, J Mirro, Jr, GH Reaman, WE Evans, C McCully, KM Doherty, RF Murphy, S Jeffries, and DG Poplack |
| |
JCO Dec 1 1988: 1882–1886.
[Abstract]
[PDF]
|
 |
|
Malignancy-associated Sweet's syndrome: review of the world literature |
| |
PR Cohen, M Talpaz, and R Kurzrock |
| |
JCO Dec 1 1988: 1887–1897.
[Abstract]
[PDF]
|
 |
| Aging and cancer |
| BJ Kennedy |
|
JCO Dec 1 1988: 1903–1911.
[PDF]
|
 |